Trials / Unknown
UnknownNCT00808964
Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery
Phase 2 Study of NU172 Anticoagulation in Patients Undergoing Coronary Artery Bypass Graft Surgery OFF-Pump
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- ARCA Biopharma, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 2, multicenter, open-label, single-arm, sequential cohort study to be conducted in up to 30 subjects. The study will evaluate subjects undergoing primary, elective, off-pump CABG surgery with median sternotomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NU172 | NU172 administered IV bolus followed by continuous infusion during CABG surgery |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-06-01
- Completion
- 2013-09-01
- First posted
- 2008-12-16
- Last updated
- 2011-06-10
Source: ClinicalTrials.gov record NCT00808964. Inclusion in this directory is not an endorsement.